Physician profile
Brian Dibble Call
NPI 1851478127
$4,960.24
in general payments reported to CMS, 2019-2025
12 companies · $206 in 2025
The $206 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $1,710 · 2021: $447 · 2022: $130 · 2023: $2,032 · 2024: $302 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,685 · Entertainment: $500 · Education: $288 · Gift: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.99 |
| Entertainment | $500.00 |
| Education | $287.50 |
| Gift | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,201.97 | 2019-2025 | Ah Plus Biocermanic Sealer, Ossix Plus, Cerec |
| A-Dec, INC. | $1,566.95 | 2020 | |
| Ormco Corporation | $385.78 | 2021-2023 | Spark, Damon |
| Nobel Biocare USA | $340.52 | 2023 | Nobelactive |
| Envista Holdings Corporation | $277.38 | 2024-2025 | Spark, Damon |
| Straumann USA LLC | $84.55 | 2024 | |
| Biohorizons Implant Systems INC. | $26.51 | 2025 | Biohorizons Dental Implants |
| Kerr Corporation | $25.21 | 2020 | |
| Gc America INC. | $14.31 | 2025 | G-Aenial, G-Premio Bond, Everx Flow |
| Solventum Corporation | $13.97 | 2024 | 3m Scotchbond, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Relyx |
| 3m Company | $13.85 | 2019 | |
| Ultradent Products INC | $9.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.